CJC-1295 Dosage Guide: DAC vs No DAC, Protocols & Timing

CJC-1295 is the most widely used GHRH (growth hormone-releasing hormone) analog in the peptide community. It works by stimulating your pituitary gland to produce and release more growth hormone — not by injecting synthetic GH directly, but by amplifying your body's own production. The result is improved sleep, better recovery, gradual body composition changes, and the broader anti-aging benefits associated with optimized GH levels.

But here's where most people get confused: there are two distinct versions of CJC-1295, and they require completely different dosing protocols. Using the wrong protocol for the wrong version is one of the most common mistakes in the peptide space. This guide breaks down both variants, explains the practical differences, and gives you clear dosing frameworks for each.

Note: This is educational content based on community experience and published research. CJC-1295 is sold as a research peptide. Always consult a healthcare provider before starting any new protocol.

CJC-1295 DAC vs No DAC: Understanding the Two Versions

The single most important thing to understand about CJC-1295 is that the name covers two fundamentally different peptides. They share the same base amino acid sequence, but their pharmacokinetics — how long they stay active in your body — are drastically different. This means different dosing frequencies, different injection schedules, and different effects on your GH profile.

CJC-1295 with DAC (Drug Affinity Complex)

The DAC version has a chemical modification that allows it to bind to albumin in the blood, dramatically extending its half-life to approximately 6–8 days. This means a single injection produces sustained, elevated GH levels for nearly a week. The GH release pattern is more of a constant, moderate elevation rather than sharp pulsatile spikes. This is the "set it and forget it" version — you inject once or twice per week and maintain consistently elevated GH output.

CJC-1295 without DAC (Mod GRF 1-29)

The no-DAC version, also known as Modified GRF 1-29 or simply Mod GRF, has a much shorter half-life of roughly 30 minutes. It produces a sharp, pulsatile burst of GH release that more closely mimics the body's natural GH secretion pattern. Because it clears the system quickly, it needs to be injected 1–3 times daily. This is the version most commonly paired with GHRPs (growth hormone-releasing peptides) like Ipamorelin for synergistic GH release.

Which one should you choose? If you want the most physiologically natural GH release pattern and don't mind multiple daily injections, go with no-DAC (Mod GRF 1-29) paired with a GHRP. If you prefer convenience and sustained elevation with minimal injections, the DAC version is the better fit. Most experienced users in the community lean toward the no-DAC version for its more natural pulsatile release and synergy with Ipamorelin.

CJC-1295 No DAC (Mod GRF 1-29) Dosing Protocol

The no-DAC version is the more commonly used variant, especially when paired with Ipamorelin or other GHRPs. Its short half-life means dosing frequency matters a lot — you're trying to create discrete GH pulses throughout the day, similar to what your body does naturally.

Practical note: Most users inject 100mcg of Mod GRF 1-29 combined with 100mcg of Ipamorelin in the same syringe. They can be mixed and injected together subcutaneously — there's no need for separate injections. See our reconstitution guide for preparation details.

CJC-1295 with DAC Dosing Protocol

The DAC version requires a completely different approach due to its extended half-life. Instead of multiple daily injections, you're looking at once or twice per week dosing. The sustained GH elevation means you don't need to worry about timing around meals or sleep the same way you do with Mod GRF 1-29.

Important distinction: The DAC version creates a constant, elevated baseline of GH rather than discrete pulses. Some researchers and clinicians prefer the pulsatile pattern (no-DAC) because it more closely mirrors natural physiology. Others argue the sustained elevation from DAC produces better real-world results for body composition and recovery. Both approaches have vocal advocates.

DAC vs No DAC: Side-by-Side Comparison

Here's a quick reference comparing the two versions across the dimensions that matter most for practical dosing decisions:

Pairing CJC-1295 with Ipamorelin: The Gold Standard Stack

The CJC-1295 (no DAC) + Ipamorelin combination is considered the gold standard GH secretagogue stack in the peptide community. The two peptides work through complementary mechanisms — CJC-1295 acts as a GHRH analog that tells the pituitary to release GH, while Ipamorelin is a ghrelin mimetic that amplifies the GH release signal. Together, they produce a GH pulse substantially larger than either peptide alone, while Ipamorelin's selectivity helps avoid the cortisol and prolactin increases associated with less selective GHRPs like GHRP-6.

For a deeper dive into building multi-peptide protocols, see our peptide stacking guide.

Timing Strategies

Timing matters significantly for CJC-1295 no-DAC (Mod GRF 1-29) but much less for the DAC version. Since most users run the no-DAC variant, here's how to optimize your injection timing:

• •Inject on an empty stomach. GH release is blunted by elevated blood sugar and insulin. Wait at least 2 hours after eating before injecting, and avoid eating for 20–30 minutes after. This is the single most important timing consideration.
• •Before bed is the priority dose. Your body naturally releases the largest GH pulse during the first cycle of deep sleep. Injecting CJC-1295 + Ipamorelin 15–30 minutes before bed amplifies this natural surge. If you only inject once daily, this is the time to do it.
• •Morning injection (optional second dose). If dosing twice daily, the morning injection should be done fasted — before breakfast or at least 2 hours after any overnight snacking. Some users wake up, inject, then wait 20–30 minutes before eating.
• •Post-workout (optional third dose). For those running the aggressive 3x daily protocol, a post-workout injection capitalizes on the natural exercise-induced GH response. Inject before your post-workout meal.
• •Avoid injecting with high-glycemic meals. Carbohydrate-heavy meals spike insulin, which directly suppresses GH release. Fat and protein have a much smaller effect. If you need to eat close to injection time, keep the meal low-carb.

For CJC-1295 with DAC: Timing is much less critical. The sustained elevation means you can inject at any time of day, with or without food, and the impact on overall GH levels is minimal. Most users pick a consistent day of the week and inject at whatever time is convenient.

Cycle Length and Structure

Unlike healing peptides like BPC-157 that you run until an injury resolves, GH secretagogues like CJC-1295 are typically cycled to maintain receptor sensitivity and avoid potential long-term downregulation of the GH axis.

• •Standard cycle: 8–12 weeks on. This is the most common protocol length. It's long enough to see meaningful body composition changes while giving your pituitary a break afterward. Most users settle on 12 weeks as the sweet spot.
• •Off period: 4 weeks minimum. After completing a cycle, take at least 4 weeks off before starting another. This allows GH receptor sensitivity to recover and ensures your pituitary isn't being continuously stimulated. Some users extend this to 6–8 weeks.
• •Why cycling matters. Continuous GHRH stimulation may eventually desensitize the pituitary, reducing the GH response over time. Cycling preserves the effectiveness of each subsequent protocol. Users who run CJC-1295 without breaks often report diminishing returns after 3–4 months.
• •5 on / 2 off within a cycle. Some users dose Monday through Friday and take weekends off. This micro-cycling approach may help maintain receptor sensitivity during the cycle itself, though the evidence is largely anecdotal. It also reduces total peptide usage by roughly 30%.

Suggested cycle structure: 12 weeks of CJC-1295 (no DAC) + Ipamorelin, dosed nightly before bed, followed by a 4–6 week break. Repeat as desired. Track your doses, sleep quality, and body composition with a free tracker so you have objective data to evaluate each cycle.

What to Expect: Timeline of Effects

GH secretagogues are not fast-acting compounds. Unlike exogenous GH, which floods the body with supraphysiological levels immediately, CJC-1295 works by gradually increasing your own production. Set realistic expectations and give it time. Here's what users typically report at each stage. For a broader overview across multiple peptide categories, see our peptide results timeline.

Side Effects and Safety Considerations

CJC-1295 is generally well-tolerated, and most side effects are mild and transient. However, there are some important things to be aware of, particularly with the DAC version:

• •Water retention. Mild bloating and water retention are common in the first 1–2 weeks as GH levels increase. This typically subsides as the body adjusts. Staying hydrated and keeping sodium intake moderate can help.
• •Tingling and numbness. Tingling in the fingers and hands, sometimes called "pins and needles," is a well-known sign of elevated GH. It's usually mild and intermittent. If it becomes persistent or uncomfortable, consider reducing the dose.
• •Increased hunger. More noticeable with the DAC version and when paired with less selective GHRPs like GHRP-6. Ipamorelin causes minimal appetite increase, which is one reason it's the preferred GHRP pairing.
• •Cortisol concerns with DAC. The sustained GH elevation from the DAC version may lead to a mild, chronic increase in cortisol levels. This is less of a concern with the pulsatile no-DAC version, where GH spikes and returns to baseline between doses. If you're sensitive to cortisol-related effects (anxiety, poor sleep, stubborn belly fat), the no-DAC version may be the safer choice.
• •Injection site reactions. Mild redness, swelling, or itching at the injection site. These are generally minor and resolve within a few hours. Rotating injection sites helps minimize this.
• •Head rush or flushing. Some users experience a brief flushing sensation or light-headedness shortly after injection. This is more common in the first week and typically diminishes as the body adapts.

When to be cautious: Individuals with a history of cancer should approach GH secretagogues carefully, as elevated GH and IGF-1 may theoretically promote the growth of existing tumors. Anyone with diabetes or insulin resistance should monitor blood glucose, as GH can affect insulin sensitivity. As with any research peptide, working with a knowledgeable healthcare provider is strongly recommended.

Track Your CJC-1295 Protocol

CJC-1295 protocols are more complex than single-peptide regimens — you're managing dose timing around meals and sleep, potentially pairing with Ipamorelin, tracking injection schedules across multi-week cycles, and monitoring subtle changes in sleep, recovery, and body composition over months. That's a lot to keep track of in your head or a spreadsheet.

Peptide Assistant lets you log every dose, track your cycle timing, note side effects, and see your protocol history at a glance — all from your phone or desktop. It's free, private, and takes less than a minute to set up. Whether you're running your first CJC-1295 cycle or dialing in an advanced GH secretagogue stack, having organized data makes it easier to evaluate what's working and share meaningful information with your healthcare provider.